Santhera Announces Approval In Hong Kong For AGAMREE® (Vamorolone) As A Treatment For Duchenne Muscular Dystrophy
(MENAFN- GlobeNewsWire - Nasdaq) Department of health (DoH) of Hong Kong approved AGAMREE® for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 4 years and older Follows recent approval from China's National Medical Products …